×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Monsoon Tracker
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Invest in Unlisted Shares
Specials
Pharma Industry Conclave
Unlocking opportunities in Metal and Mining
#MFSummit2025
Moneycontrol mutual fund summit 2025
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
Personal Finance
Forum
Videos
you are here:
Home
News
Halol
Halol
Ads
USFDA pulls up Sun Pharma for lapses in Halol plant
FDA's warning letter points to cGMP violations at Halol facility: Sun Pharma
Sun Pharma: Strong speciality show, scale-up in clinical trials awaited
US FDA flags quality lapses at Sun Pharma's Gujarat plant: Report
Sun Pharma: Traction in speciality likely to sustain
Sun Pharma: Sustained traction in speciality to be a re-rating driver
Sun Pharma’s steady India business and US speciality portfolio should help it do well in FY22
Analysts retain buy on Sun Pharma as USFDA clears Mohali, Halol unit resolution key
Here are Sanjiv Bhasin's top trading ideas
Sun Pharma up 3% as co may shift key products from Halol plant
Nifty on Cloud Nine! 9 stocks with a high margin of safety
USFDA report on Halol unit to be positive in long-term: Sun
Do not see any urgency to buy Sun Pharma, says Dipan Mehta
Sun Pharma rebounds, Halol unit observations not worrisome
Sun Pharma up 2% as USFDA issues 9 observations for Halol unit
Sun Pharma down 6% on 14-page USFDA observations letter to Halol
Sun Pharma falls 7%, sector under pressure on US probe fear
Sun Pharma Q1 net seen at Rs 1894 cr, US sales likely at $598 mn
Hero MotoCorp inks 3-year wage agreement with Gurgaon workers
Sun Pharma falls 6% on weak sales guidance, price pressure woes
Analysts bet psoriasis drug to aid Sun Pharma's US kitty
LM Power commissions second manufacturing facility in India
Export weakness, Chinese truck radials dumping a worry: Ceat
Sun Pharma to ask FDA in Q1 FY17 for Halol re-inspection
Sun Pharma Q3 profit seen up 4.4%, Gleevec & Halol key
View More
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio